QJM · 2023 · 34 citations · 23 references
MedicineEndocrinologyDiabetologyNutritional EpidemiologyPreventive CardiologyDiabetes MellitusGlycemic ControlHypertension ControlHypertension PreventionMetabolic VariabilityBlood PressureCohort Study InvestigationFasting GlycemiaGlucose Variability AssessmentSystolic Blood Pressure
BACKGROUND: Several studies have indicated that the triglyceride-glucose index (TyG) index is associated with hypertension; however, evidence on the association of change in the TyG index with blood pressure and hypertension is limited. AIMS: To assess the association of the TyG index with blood pressure and hypertension. DESIGN: A cohort study. METHODS: We included 17 977 individuals with a mean age of 60.5 years from the Dongfeng-Tongji cohort. The TyG index was calculated as ln [fasting triglyceride (mg/dl)×fasting glucose (mg/dl)/2]. Hypertension was defined as blood pressure ≥140/90 mmHg, self-reported current use of antihypertensive medication or self-reported physician diagnosis of hypertension. RESULTS: In the longitudinal analyses, we found a linear dose-response relationship between changes in the TyG index and change in blood pressure. Each one-unit change in the TyG index was associated with a 1.93 (1.23-2.63) mmHg increase in systolic blood pressure (SBP) and a 1.78 (1.42-2.16) mmHg increase in diastolic blood pressure (DBP). During a median follow-up of 9.37 years, a total of 3594 individuals were newly diagnosed with hypertension. We also found a linear dose-response relationship between the TyG index and the incidence of hypertension. The hazard ratio (HR) of hypertension for each one-unit increase in the TyG index was 1.21 (1.13-1.29). In addition, the best cut-off point of TyG for predicting hypertension was 8.4797, with sensitivity, and specificity of 57.85% and 55.40%, respectively. CONCLUSIONS: The TyG index had a positive dose-response relationship with blood pressure and could be used to predict the risk of hypertension.
23
Bin Zhou, Rodrigo M. Carrillo‐Larco, Goodarz Danaei et al. · The Lancet · 2021 · 3.7K citations · Full text
Medicine, Chronic Disease Control, Clinical Epidemiology +16
Fernando Guerrero‐Romero, Luis E. Simental‐Mendía, Manuel González-Ortı́z et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 2.3K citations · Full text
Medicine, Endocrinology, Diabetology +15
Jiapeng Lu, Yuan Lu, Xiaochen Wang et al. · The Lancet · 2017 · 1.2K citations
Medicine, Population Health Sciences, Preventive Medicine +14
Cohort Profile: The Dongfeng–Tongji cohort study of retired workers
Feng Wang, Jiang Zhu, Ping Yao et al. · International Journal of Epidemiology · 2012 · 290 citations · Full text